By PPN News Staff
The FDA amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine, allowing children aged 5 through 11 years to receive a single 10-mcg booster dose at least five months after the completion of a primary series.
“While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer term